- Home
- UVV vs IMTX Comparison
UVV vs IMTX Comparison
Compare UVV & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UVV | IMTX |
|---|---|---|
| Founded | 1886 | N/A |
| Country | United States | Germany |
| Employees | N/A | 423 |
| Industry | Farming/Seeds/Milling | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | UVV | IMTX |
|---|---|---|
| Price | $52.91 | $9.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $19.25 |
| AVG Volume (30 Days) | 208.8K | ★ 356.3K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.23% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.02 | N/A |
| Revenue | ★ $2,922,924,000.00 | N/A |
| Revenue This Year | $0.67 | N/A |
| Revenue Next Year | $0.10 | $27.52 |
| P/E Ratio | $17.51 | ★ N/A |
| Revenue Growth | ★ 7.40 | N/A |
| 52 Week Low | $49.96 | $3.30 |
| 52 Week High | $67.33 | $12.41 |
Technical Indicators
Market Signals| Indicator | UVV | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.63 | 48.10 |
| Support Level | $51.72 | $9.66 |
| Resistance Level | $54.01 | $10.64 |
| Average True Range (ATR) | 0.94 | 0.53 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 34.31 | 41.89 |
Price Performance
Historical ComparisonAbout UVV Universal Corporation
Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.